These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 14982876)
1. The biology of CML blast crisis. Calabretta B; Perrotti D Blood; 2004 Jun; 103(11):4010-22. PubMed ID: 14982876 [TBL] [Abstract][Full Text] [Related]
2. Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML. Honda H; Ushijima T; Wakazono K; Oda H; Tanaka Y; Aizawa Si; Ishikawa T; Yazaki Y; Hirai H Blood; 2000 Feb; 95(4):1144-50. PubMed ID: 10666183 [TBL] [Abstract][Full Text] [Related]
3. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Dash AB; Williams IR; Kutok JL; Tomasson MH; Anastasiadou E; Lindahl K; Li S; Van Etten RA; Borrow J; Housman D; Druker B; Gilliland DG Proc Natl Acad Sci U S A; 2002 May; 99(11):7622-7. PubMed ID: 12032333 [TBL] [Abstract][Full Text] [Related]
4. [Research advance on molecular genetics of CML blast crisis]. Zhu HQ; Zhang S; Liu XL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935 [TBL] [Abstract][Full Text] [Related]
8. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia. Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536 [TBL] [Abstract][Full Text] [Related]
9. ABL amplification in a patient with lymphoid blast crisis of chronic myelogenous leukaemia. Kenner L; Beham-Schmid C; Kerbl R; Schmidt HH; Sill H; Hoefler G Virchows Arch; 1999 Mar; 434(3):255-7. PubMed ID: 10190307 [TBL] [Abstract][Full Text] [Related]
10. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia. Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728 [TBL] [Abstract][Full Text] [Related]
12. Chronic myelogenous leukemia: molecular and cellular aspects. Pasternak G; Hochhaus A; Schultheis B; Hehlmann R J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825 [TBL] [Abstract][Full Text] [Related]
13. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973 [TBL] [Abstract][Full Text] [Related]
14. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients. Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454 [TBL] [Abstract][Full Text] [Related]
15. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597 [TBL] [Abstract][Full Text] [Related]
16. Blast crisis in a murine model of chronic myelogenous leukemia. Daley GQ; Van Etten RA; Baltimore D Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11335-8. PubMed ID: 1763047 [TBL] [Abstract][Full Text] [Related]
17. Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Nakahara F; Sakata-Yanagimoto M; Komeno Y; Kato N; Uchida T; Haraguchi K; Kumano K; Harada Y; Harada H; Kitaura J; Ogawa S; Kurokawa M; Kitamura T; Chiba S Blood; 2010 Apr; 115(14):2872-81. PubMed ID: 19861684 [TBL] [Abstract][Full Text] [Related]
18. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia]. Okabe M Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066 [TBL] [Abstract][Full Text] [Related]
19. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients. Nakajima H; Zhao R; Lund TC; Ward J; Dolan M; Hirsch B; Miller JS J Immunol; 2002 Jan; 168(2):643-50. PubMed ID: 11777957 [TBL] [Abstract][Full Text] [Related]
20. A hypothetical model to explain the 'termination' of chronic myeloid leukemia into blastic crisis. Banavali SD; Advani SH Med Hypotheses; 1991 Feb; 34(2):111-5. PubMed ID: 2041482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]